Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Vascular Grafts Overview 8
3 Products under Development 9
3.1 Vascular Grafts – Pipeline Products by Stage of Development 9
3.2 Vascular Grafts – Pipeline Products by Segment 10
3.3 Vascular Grafts – Pipeline Products by Territory 11
3.4 Vascular Grafts – Pipeline Products by Regulatory Path 12
3.5 Vascular Grafts – Pipeline Products by Estimated Approval Date 13
3.6 Vascular Grafts – Ongoing Clinical Trials 14
4 Vascular Grafts – Pipeline Products under Development by Companies 15
4.1 Vascular Grafts Companies – Pipeline Products by Stage of Development 15
4.2 Vascular Grafts – Pipeline Products by Stage of Development 17
5 Vascular Grafts Companies and Product Overview 19
5.1 Angiograft LLC Company Overview 19
5.1.1 Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Ariste Medical LLC Company Overview 20
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Aruga Technologies LLC Company Overview 21
5.3.1 Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 Biosurfaces Inc Company Overview 22
5.4.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Cardiojustable LLC (Inactive) Company Overview 23
5.5.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Cardiovate Company Overview 24
5.6.1 Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Colorado Therapeutics, LLC Company Overview 25
5.7.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 CryoLife Inc Company Overview 26
5.8.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Cytograft Tissue Engineering Inc (Inactive) Company Overview 27
5.9.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
5.10 DSM Biomedical BV Company Overview 29
5.10.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Eqalix Inc Company Overview 30
5.11.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 FIT Biotech Oy Company Overview 32
5.12.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Gel-Del Technologies, Inc. Company Overview 34
5.13.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.14 Humacyte Inc Company Overview 35
5.14.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.15 Innovia LLC Company Overview 41
5.15.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 LeMaitre Vascular Inc Company Overview 42
5.16.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.17 Merit Medical Systems Inc Company Overview 44
5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 44
5.18 Nationwide Children’s Hospital Company Overview 45
5.18.1 Nationwide Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 45
5.19 Northwestern University Company Overview 46
5.19.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 46
5.20 Peca Labs Inc Company Overview 47
5.20.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 47
6 Vascular Grafts- Recent Developments 64
6.1 Nov 04, 2019: PQ Bypass initiates pivotal study of next-generation advancement in Stent Graft Technology for Treatment of Patients with Peripheral Artery Disease 64
6.2 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 64
6.3 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 65
6.4 Oct 23, 2019: LeMaitre Vascular announces Q3 2019 financial results 67
6.5 Oct 15, 2019: LifeNet Health establishes world’s first dedicated regenerative medicine logistics and distribution center in Indianapolis 68
7 Appendix 88
7.1 Methodology 88
7.2 About GlobalData 91
7.3 Contact Us 91
7.4 Disclaimer 91
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Table 2: Vascular Grafts - Pipeline Products by Segment 10
Table 3: Vascular Grafts - Pipeline Products by Territory 11
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Table 6: Vascular Grafts - Ongoing Clinical Trials 14
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 15
Table 8: Vascular Grafts - Pipeline Products by Stage of Development 17
Table 9: Angiograft LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 10: Vascular Graft - Product Status 19
Table 11: Vascular Graft - Product Description 19
Table 12: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 13: Drug Eluting Vascular Graft - Product Status 20
Table 14: Drug Eluting Vascular Graft - Product Description 20
Table 15: Aruga Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 21
Table 16: Topograft - Product Status 21
Table 17: Topograft - Product Description 21
Table 18: Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 19: BioFunc - APC Vascular Graft - Product Status 22
Table 20: BioFunc - APC Vascular Graft - Product Description 22
Table 21: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 23
Table 22: Adjustable SPA Shunt - Product Status 23
Table 23: Adjustable SPA Shunt - Product Description 23
Table 24: Cardiovate Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: NeoVessel Vascular Graft - Product Status 24
Table 26: NeoVessel Vascular Graft - Product Description 24
Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
Table 33: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: Lifeline TEBV - Lower Limb - Product Status 27
Table 35: Lifeline TEBV - Lower Limb - Product Description 27
Table 36: LifeLine TEBV - Pediatric - Product Status 28
Table 37: LifeLine TEBV - Pediatric - Product Description 28
Table 38: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 29
Table 39: Small Diameter Vascular Graft - Product Status 29
Table 40: Small Diameter Vascular Graft - Product Description 29
Table 41: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: CardioVessel - Product Status 30
Table 43: CardioVessel - Product Description 30
Table 44: LCL Graft - Product Status 31
Table 45: LCL Graft - Product Description 31
Table 46: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 32
Table 47: GTU X-Graft - Product Status 32
Table 48: GTU X-Graft - Product Description 32
Table 49: GTU X2-Graft - Product Status 33
Table 50: GTU X2-Graft - Product Description 33
Table 51: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 52: VasoGraft - Product Status 34
Table 53: VasoGraft - Product Description 34
Table 54: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 55: HUMACYL - Peripheral Artery Disease - Product Status 35
Table 56: HUMACYL - Peripheral Artery Disease - Product Description 35
Table 57: HUMACYL Graft - CABG - Product Status 36
Table 58: HUMACYL Graft - CABG - Product Description 36
Table 59: HUMACYL Graft - Vascular Trauma - Product Status 36
Table 60: HUMACYL Graft - Vascular Trauma - Product Description 37
Table 61: Humacyte Inc - Ongoing Clinical Trials Overview 38
Table 62: HUMACYL Graft - Vascular Trauma - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Vascular Replacement or Reconstruction in Patients with Life or Limb-threatening Vascular Trauma 39
Table 63: HUMACYL - Peripheral Artery Disease - A Phase II Study for the Evaluation of Safety and Efficacy of Humacyte's Human Acellular Vessel for Use as a Vascular Prosthesis for Femoro-popliteal Bypass in Patients with Peripheral Arterial Disease 40
Table 64: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 65: 4mm Vascular Graft - Product Status 41
Table 66: 4mm Vascular Graft - Product Description 41
Table 67: LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 68: LifeSpan ePTFE Vascular Graft - Product Status 42
List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 9
Figure 2: Vascular Grafts - Pipeline Products by Segment 10
Figure 3: Vascular Grafts - Pipeline Products by Territory 11
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 12
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 13
Figure 6: Vascular Grafts - Ongoing Clinical Trials 14
【免責事項】
https://www.marketreport.jp/reports-disclaimer